TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
ANTX

AN2 Therapeutics Inc

Healthcare · Biotechnology

4.90$ -0.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

AN2 Therapeutics Inc (ANTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 82 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ANTX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
154 139 121 108 98 92 81 76 67 62 87 82
126 111 116 107 98 86 70 68 64 60 87 80
33 16 25 27 34 21 20 18 18 20 53 44
124 107 114 105 93 84 67 63 62 58 85 78
– 1.4 0.5 0.3 1.0 0.3 0.3 2.7 0.4 0.9 0.3 0.3
15 14 11 10 10 10 8.0 7.0 6.9 8.9 5.7 5.8
15 14 11 10 10 10 8.0 2.1 6.9 8.7 5.6 5.6
4.9 2.7 2.4 1.9 1.7 3.3 3.1 2.1 2.2 3.0 2.6 2.0
139 125 111 98 88 82 73 69 60 53 82 76
-138 -154 -171 -186 -198 -206 -216 -223 -232 -241 -251 -259
26 30 30 30 30 30 30 30 30 30 34 45

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?